Form 4: CG Oncology Executive Receives Stock Grant
Insider Transaction (Form 4)
Isabel Kalofonos, Chief Commercial Officer of CG Oncology, Inc., received 92,000 shares of common stock on October 15, 2026.
Summary
- Grant/award: acquired 92,000 Employee Stock Option (right to buy) on October 15, 2026; holds 92,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Isabel Kalofonos — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Grant/award | Employee Stock Option (right to buy) | 92,000 | — | — | 92,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Grant/award (92,000 shares) |
Keywords
insider transaction, Form 4, CGON, CG Oncology, Inc., neutral, Isabel Kalofonos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.